News & Events

The Antibody Series 2022

View full agenda and timings: Full Agenda

RSVP your place at the Official Antibody Series Website

Join the Antibody Series 2022 Community


The Antibody Series is a unique event exploring innovative ideas in antibody discovery and development. After the success of last year’s inaugural event combining superb presentations, excellent networking opportunities and festivities, we’re pleased to announce that the series will take place across two full-days on the 7th and 8th September.

This September, we will see a great line-up of expert speakers from Industry and Academia present across exciting topics in the antibody field.

Topics that will be discussed and presented on at this year’s meeting are:

  • Artificial Intelligence and Antibodies
  • Antibody Discovery
  • The Blood Brain Barrier and Targeting Neurodegenerative Diseases
  • Affinity, Avidity & Novel Mechanisms of Action
  • Targeting the Tumor Micro-environment

Each session will also conclude with a panel discussion and an opportunity for you to ask questions to the panel of speakers.



This year’s meeting will take place at the iconic Super Bock Arena, located in Porto, Portugal idyllically placed next to the Douro River.

Address: Super Bock Arena, Jardins do Palácio de Cristal, R. de Dom Manuel II, 4050-346 Porto, Portugal

Google maps: Location


Agenda 2022

The Blood Brain Barrier and Targeting Neurodegenerative Diseases

  • Joe Lewcock
    Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle
  • Sander van Deventer
    Next generation vectorized antibody therapies for neurodegenerative diseases

Affinity, Avidity & Novel Mechanisms of Action

  • Paul Parren
    Avidity engineering of antibodies
  • Peter Tessier
    Drug-like antibodies by design and directed evolution

Antibody Technology and Optimization

  • Rene Hoet
    New Technology Developments for Future (Multispecific) Antibody Discovery and Optimization.

Artificial Intelligence and Antibodies

  • Yanay Ofran
    Reimaging therapeutics antibodies using artificial intelligence
  • Aridaman Pandit
    Transforming immunology and target discovery using machine learning

Antibody Discovery

  • Jane Osbourn
    Mining the immune system for protective antibodies
  • Marta Amaral
    Trispecific antibodies as the next generation of T cell immunotherapy
  • Daniel Bedinger
    High resolution epitope binning informs antibody drug discovery for infectious disease and enhances next generation antibody workflows

Novel Mechanisms of Action

  • Pablo Umaña
    Enhancing endogenous and synthetic immunity with engineered antibody-fusion proteins for cancer immunotherapy
  • John de Kruif
    Discovery of a trispecific T cell engager for solid tumors
  • Nathan Robertson
    The Two Sides of Targeting Checkpoint Receptors
  • Fernando Garces
    NextGen Biologics Engineering

Protein Sciences

  • Teresa Barata
    FairJourney Biologics Presentation
  • António Barroso
    Stable cell line development for Antibody Discovery and Production

Targeting the Tumor Micro-environment

  • Horacio Nastri
    Inhibiting the Adenosine pathway for cancer therapeutics
  • Jonathan Davis
    Using the B-Body Bispecific Platform to Specifically Target and Eliminate Tumor-resident Tregs


Learn more about us

FairJourney Biologics is a leading biologics CRO, providing integrated services across antibody discovery, engineering and production to global biopharma. The Company’s significant expertise in phage display technology, combined with a diverse approach to generating both immune and naïve antibody libraries have contributed to a market leading 99%+ project success rate.

Get in touch with us
This site uses cookies to provide you with a great user experience. By using our website, you accept our use of cookies.